RadNet has acquired CIMAR UK, a cloud-based medical imaging services firm headquartered in London.
CIMAR will be integrated into its subsidiary DeepHealth, RadNet said. The companies have previously partnered in England’s lung cancer screening program. CIMAR provides the digital infrastructure connecting DeepHealth’s AI lung cancer detection model across more than 90% of the program’s screening sites, RadNet noted.
With the acquisition, DeepHealth aims to scale digitally enabled new and more efficient care models across the U.K. and Europe for other screening and diagnostic programs, RadNet said. Terms of the deal were not disclosed.













![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





